Fedricker D Barber, Erick Campbell, Yuko Yamamura, Clover J Patterson, Audrey C Hartnett, Holly Kinahan, Victoria A Miller, Amanda L Brink, Anna Poullard, Gabriele E Urschel, Andre Brantley, Isabel G Cepeda, Poonam Goswami, Sheena Charles, Shincy Philip, Sara Bresser, Sandra Musekiwa-Adjei, Nageli Perez, Hung Le, Penny Phillips, Vivek Subbiah, Funda Meric-Bernstam, Ecaterina E Dumbrava
Background: Advanced practice providers (APPs) play important roles in enrolling, educating, and caring for patients in clinical trials. However, much remains unknown about the role of APPs in managing adverse events (AEs) in early (phase I to II) clinical trials. In this study, we assessed the outpatient management of grade 3 to 4 AEs by APPs in early trials and characterized the workflow of our APP Phase I to II Fast Track (FT) Clinic. Patients and Methods: We retrospectively reviewed records of patients with advanced or metastatic solid tumors enrolled in phase I to II clinical trials who were seen by APPs from September 2017 to August 2018 in the APP phase I to II FT clinic in the Department of Investigational Cancer Therapeutics...
September 2022: Journal of the Advanced Practitioner in Oncology